Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD.
This presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they manage the complexities of their care regimen. Health literacy is crucial for dialysis and transplant patients so they can be empowered to participate in shared decision-making.
This presentation will underscore the critical role of nutrition/diet interventions to slow CKD progression, avoid or delay end-stage kidney disease transition, and improve patient outcomes.
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD).
This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on patients living with kidney. Diagnosing and managing the care of patients living with ADPKD will also be discussed.
In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed.
In this presentation, we will discuss the important role of imaging in diagnosis and prognosis of ADPKD, including measuring TKV, looking at complications and more.
This presentation for patients will discuss how Polycystic Kidney Disease (PKD) develops, how the disease changes over time, and how it affects patients both physically and mentally.
